A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

Recruiting

Phase 2

NNC0662-0419A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

Sponsor:

Novo Nordisk A/S

Code:

NCT07639021

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NNC0662-0419

Semaglutide

NNC0662-0419 Placebo

Semaglutide placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-23. This information was provided to ClinicalTrials.gov by Novo Nordisk A/S on 2026-07-10.